1-8 of 8
Vera Gelbricht
Close
Sort by
Journal Articles

Drug Persistence with Rivaroxaban Therapy in Atrial Fibrillation Patients Results from the Dresden NOAC registry

Jan Beyer-Westendorf, MD, Kati Förster, Franziska Ebertz, Vera Gelbricht, Franziska Michalski, Luise Tittl, Norbert Weiss, Prof.
Journal: Blood
Blood (2014) 124 (21): 4264.
https://doi.org/10.1182/blood.V124.21.4264.4264
Published: 2014
Journal Articles

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Clinical Trials & Observations
Jan Beyer-Westendorf, Kati Förster, Sven Pannach, Franziska Ebertz, Vera Gelbricht, Christoph Thieme, Franziska Michalski, Christina Köhler, Sebastian Werth, Kurtulus Sahin, Luise Tittl, Ulrike Hänsel, Norbert Weiss
Journal: Blood
Blood (2014) 124 (6): 955–962.
https://doi.org/10.1182/blood-2014-03-563577
Published: 2014
Includes: Supplemental data
Journal Articles

Pattern and Management Of Bleeding Complications With Novel Oral Anticoagulants – Results Of The Prospective Dresden Noac Registry (NCT01588119)

Kati Förster, Franziska Ebertz, Vera Gelbricht, Denise Röllig, Luise Tittl, Christina Köhler, MD, Sebastian Werth, MD, Jan Beyer-Westendorf, MD
Journal: Blood
Blood (2013) 122 (21): 214.
https://doi.org/10.1182/blood.V122.21.214.214
Published: 2013
Journal Articles

Real Life Efficacy and Safety of Rivaroxaban for Extended VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119).

Christina Koehler, Sebastian Werth, MD, Vera Gelbricht, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Maria Eulitz, Jan Beyer-Westendorf, MD
Journal: Blood
Blood (2012) 120 (21): 2267.
https://doi.org/10.1182/blood.V120.21.2267.2267
Published: 2012
Journal Articles

Real Life Efficacy and Safety of Rivaroxaban for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Sebastian Werth, MD, Christina Koehler, Vera Gelbricht, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Jan Beyer-Westendorf, MD
Journal: Blood
Blood (2012) 120 (21): 1156.
https://doi.org/10.1182/blood.V120.21.1156.1156
Published: 2012
Journal Articles

Real Life Efficacy and Safety of Rivaroxaban for Acute VTE Treatment – First Results of the Prospective Noac Registry (NCT01588119)

Vera Gelbricht, Christina Koehler, Sebastian Werth, MD, Ulrike Haensel, Thomas Schreier, Maria Eulitz, Luise Tittl, Ines Beyer-Westendorf, Jan Beyer-Westendorf, MD
Journal: Blood
Blood (2012) 120 (21): 1159.
https://doi.org/10.1182/blood.V120.21.1159.1159
Published: 2012
Journal Articles

Real Life Efficacy and Safety of Dabigatran for Stroke Prevention in Atrial Fibrillation – First Results of the Prospective Noac Registry (NCT01588119)

Vera Gelbricht, Sebastian Werth, MD, Christina Koehler, Ulrike Haensel, Luise Tittl, Ines Beyer-Westendorf, Thomas Schreier, Jan Beyer-Westendorf, MD
Journal: Blood
Blood (2012) 120 (21): 502.
https://doi.org/10.1182/blood.V120.21.502.502
Published: 2012
Journal Articles

Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)

Vera Gelbricht, Christina Koehler, Sebastian Werth, MD, Ulrike Haensel, Thomas Schreier, Tittl Luise, Maria Eulitz, Ines Beyer-Westendorf, Jan Beyer-Westendorf, MD
Journal: Blood
Blood (2012) 120 (21): 1173.
https://doi.org/10.1182/blood.V120.21.1173.1173
Published: 2012